3SBio eyes comeback listing in Hong Kong this year
Chinese biotech company 3SBio, which was listed on the Nasdaq, is making a return to the equity capital markets, this time with a listing in Hong Kong.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts